Maternal knowledge, attitudes and beliefs regarding gastroenteritis and rotavirus vaccine before implementing

Alyssa Morin1, Thomas Lemaître, Anne Farrands

  • 1Département de Pédiatrie, CHU Fleurimont, Université de Sherbrooke, Québec, Canada.

Vaccine
|August 4, 2012
PubMed

Insights

Public acceptance of rotavirus vaccination is influenced by perceived infant vulnerability and physician recommendation. Key messages should highlight the vaccine

Area of Science:

  • Public Health
  • Vaccinology
  • Health Behavior

Background:

  • National Advisory Committee on Immunization (NACI) recommended rotavirus vaccines for Canadian infants in 2010.
  • Assessing public acceptability is crucial for successful vaccine implementation.
  • The Health Belief Model (HBM) provides a framework for understanding health behaviors.

Purpose of the Study:

  • To evaluate the acceptability and intention of rotavirus vaccination among pregnant or postpartum women.
  • To identify factors influencing vaccination intention using the HBM and Theory of Planned Behavior.
  • To inform public health strategies for promoting rotavirus vaccine uptake.

Main Methods:

  • Cross-sectional survey conducted at Sherbrooke University Hospital Center, Quebec.
  • Self-administered questionnaire assessing socio-demographics, gastroenteritis experience, and HBM dimensions.
  • Univariate and multivariate analyses to determine associations with vaccination intention.

Main Results:

  • Only 29% of 343 respondents had heard of rotavirus vaccination; 74% intended to vaccinate among those aware.
  • Perceived infant vulnerability (OR=2.3) and having no other children (OR=2.3) positively correlated with vaccination intention.
  • Media awareness was negatively associated (OR=0.5), while vaccine reimbursement (OR=3.0), doctor's recommendation (OR=21.2), and protection against severe forms (OR=4.4) were key positive cues.

Conclusions:

  • Public perception of infant risk and physician endorsement are critical for rotavirus vaccine acceptance.
  • Targeted communication emphasizing vaccine reimbursement and protection against severe illness is recommended.
  • Healthcare providers play a pivotal role in enhancing public trust and uptake of new vaccines.

Related Concept Videos

Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Vaccinations01:51

Vaccinations

Overview
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.